These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31223410)

  • 1. Hyporegenerative anemia and other complications of rhesus hemolytic disease: to treat or not to treat is the question.
    Alaqeel AA
    Pan Afr Med J; 2019; 32():120. PubMed ID: 31223410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyporegenerative anemia associated with Rh hemolytic disease: treatment failure of recombinant erythropoietin.
    Pessler F; Hart D
    J Pediatr Hematol Oncol; 2002 Nov; 24(8):689-93. PubMed ID: 12439047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late hyporegenerative anemia in neonates with rhesus hemolytic disease.
    al-Alaiyan S; al Omran A
    J Perinat Med; 1999; 27(2):112-5. PubMed ID: 10379500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early Hyporegenerative Anemia Complicating Hemolytic Disease of the Newborn Secondary to Rhesus Alloimmunization.
    Acosta C; Idris I; Romero R; Ablan L; Montoya Novoa A; Abdalaziz A; Rodriguez A
    Cureus; 2021 Nov; 13(11):e19603. PubMed ID: 34926072
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin as treatment for late hyporegenerative anemia in neonates with Rh hemolytic disease after in utero exchange transfusion.
    Nicaise C; Gire C; Casha P; d'Ercole C; Chau C; Palix C
    Fetal Diagn Ther; 2002; 17(1):22-4. PubMed ID: 11803211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyporegenerative anemia associated with intrauterine transfusion in rhesus hemolytic disease.
    Thorp JA; O'Connor T; Callenbach J; Cohen GR; Yeast JD; Albin J; Plapp F
    Am J Obstet Gynecol; 1991 Jul; 165(1):79-81. PubMed ID: 1853921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Rh(c), "little c," isoimmunization: the role of rHuEpo in preventing late anemia.
    Zuppa AA; Cardiello V; Alighieri G; Cota F; D'Antuono A; Riccardi R; Catenazzi P; Romagnoli C
    J Pediatr Hematol Oncol; 2013 Aug; 35(6):e269-71. PubMed ID: 23073047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant erythropoietin as treatment for the late hyporegenerative anemia of Rh hemolytic disease.
    Ohls RK; Wirkus PE; Christensen RD
    Pediatrics; 1992 Nov; 90(5):678-80. PubMed ID: 1408538
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant erythropoietin in the prevention of late anaemia in intrauterine transfused neonates with Rh-haemolytic disease.
    Zuppa AA; Maragliano G; Scapillati ME; Florio MG; Girlando P; Noia G; De Santis M; Cavaliere AF; Romagnoli C; Tortorolo G
    Fetal Diagn Ther; 1999; 14(5):270-4. PubMed ID: 10529568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of late anemia in Rhesus hemolytic disease: use of recombinant human erythropoietin (a pilot study).
    Ovali F; Samanci N; Dağoğlu T
    Pediatr Res; 1996 May; 39(5):831-4. PubMed ID: 8726237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness of recombinant human erythropoietin (EPO) treatment in a neonate with hyporegenerative anemia following Rh isoimmunization in spite of normal serum Epo level.
    Erduran E; Bahadir A
    Pediatr Hematol Oncol; 2011 Nov; 28(8):721-2. PubMed ID: 21875319
    [No Abstract]   [Full Text] [Related]  

  • 12. Late hyporegenerative anemia in Rh hemolytic disease.
    Koenig JM; Ashton RD; De Vore GR; Christensen RD
    J Pediatr; 1989 Aug; 115(2):315-8. PubMed ID: 2754561
    [No Abstract]   [Full Text] [Related]  

  • 13. Successful treatment of neonatal rhesus hemolytic anemia with high doses of recombinant human erythropoietin.
    Wacker P; Ozsahin H; Stelling MJ; Humbert J
    Pediatr Hematol Oncol; 2001 Jun; 18(4):279-82. PubMed ID: 11400653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perinatal management of fetal hemolytic disease due to Rh incompatibility combined with fetal alloimmune thrombocytopenia due to HPA-5b incompatibility.
    Schild RL; Hoch J; Plath H; Geissen C; Fahnenstich H; Dame C; Hansmann M
    Ultrasound Obstet Gynecol; 1999 Jul; 14(1):64-7. PubMed ID: 10461341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of erythropoiesis by intrauterine transfusions in hemolytic disease of the newborn: use of erythropoietin to treat the late anemia.
    Scaradavou A; Inglis S; Peterson P; Dunne J; Chervenak F; Bussel J
    J Pediatr; 1993 Aug; 123(2):279-84. PubMed ID: 8345428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of neonatal Rh disease.
    Peterec SM
    Clin Perinatol; 1995 Sep; 22(3):561-92. PubMed ID: 8521682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant human erythropoietin in the prevention of late anemia in intrauterine transfused neonates with Rh-isoimmunization.
    Zuppa AA; Alighieri G; Calabrese V; Visintini F; Cota F; Carducci C; Antichi E; Noia GA; Fortunato G; Romagnoli C
    J Pediatr Hematol Oncol; 2010 Apr; 32(3):e95-101. PubMed ID: 20216236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recombinant erythropoietin as treatment for hyporegenerative anemia following hemolytic disease of the newborn].
    Donato H; Bacciedoni V; García C; Schvartzman G; Vain N
    Arch Argent Pediatr; 2009 Apr; 107(2):119-25. PubMed ID: 19452083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Late anaemia in Rh haemolytic disease.
    Ovalý F
    Arch Dis Child Fetal Neonatal Ed; 2003 Sep; 88(5):F444; author reply F445. PubMed ID: 12937058
    [No Abstract]   [Full Text] [Related]  

  • 20. Chelation therapy for secondary neonatal iron over load: Lessons learned from rhesus hemolytic disease.
    Khdair-Ahmad F; Aladily T; Khdair-Ahmad O; Badran EF
    Turk J Pediatr; 2018; 60(3):335-339. PubMed ID: 30511551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.